In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 309956-78-3, name is (R)-tert-Butyl piperidin-3-ylcarbamate, introducing its new discovery. Product Details of 309956-78-3
Development of 5-hydroxypyrazole derivatives as reversible inhibitors of lysine specific demethylase 1
A series of reversible inhibitors of lysine specific demethylase 1 (LSD1) with a 5-hydroxypyrazole scaffold have been developed from compound 7, which was identified from the patent literature. Surface plasmon resonance (SPR) and biochemical analysis showed it to be a reversible LSD1 inhibitor with an IC50 value of 0.23?muM. Optimisation of this compound by rational design afforded compounds with Kd values of <10?nM. In human THP-1 cells, these compounds were found to upregulate the expression of the surrogate cellular biomarker CD86. Compound 11p was found to have moderate oral bioavailability in mice suggesting its potential for use as an in vivo tool compound. The proportionality constant is the rate constant for the particular unimolecular reaction. the reaction rate is directly proportional to the concentration of the reactant. I hope my blog about 309956-78-3 is helpful to your research. Product Details of 309956-78-3
Reference£º
Piperidine – Wikipedia,
Piperidine | C5H13504N – PubChem